To: Todd King who wrote (89 ) 10/30/1999 12:47:00 PM From: Mike McFarland Read Replies (1) | Respond to of 360
chipstohits.com 9am this Tuesday--Doug Dolginow, M.D., Senior Vice President, Pharmacogenetics, Gene Logic, Inc. also...Hongjun Yang, Ph.D., Gene Logic, Inc. Very good websitegene-chips.com The following paper keeps popping up as a suggested review article...if anybody has this one lying around on their desktop, I'd certainly like to have a copy of the pdf... Mike.McFarland@worldnet.att.net Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998 Jul;4(7):844-847 An article from '98 here:devicelink.com I see from the gene-chips website that Cadus is still listed for Yeast living chip. Worth a mention...I was able to snag a little of that at 3/16 before they moved the ask to 1/4. Interestingly the offer has dropped as well. Or my quotes suck...I miss the detail of level II. Do not own GLGC these days...unless somebody knows when the flow thru chip will finally be finished. Til then seems like there will be buying ops, for various reasons the stock does not look especially cheap to me anymore-- maybe that is because a small amount of additional surfin' revealed so much competition. Fellow newbies will want to snag this one as well:biomednet.com orbiomednet.com Current Opinion in Biotechnology Vol. 9, No. 6, December 1998 Technology for microarray analysis of gene expression [Review article] Andrew Watson, Abhijit Mazumder, Michael Stewart, Sriram Balasubramanian Current Opinion in Biotechnology 1998, 9:609-614. --free til the end of the year.